MOTCO’s iShares Biotechnology ETF IBB Stock Holding History

MOTCO’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.99K	Hold	42	–	–	﹤0.01%	450
2026 Q1	$7.09K	Hold	42	–	–	﹤0.01%	481
2025 Q4	$7.09K	Hold	42	–	–	﹤0.01%	499
2025 Q3	$6.06K	Hold	42	–	–	﹤0.01%	505
2025 Q2	$5.58K	Sell	42 -9	-18%	-$1.1K	﹤0.01%	462
2025 Q1	$6.52K	Hold	51	–	–	﹤0.01%	444
2024 Q4	$6.74K	Hold	51	–	–	﹤0.01%	409
2024 Q3	$7.43K	Sell	51 -275	-84%	-$39.8K	﹤0.01%	496
2024 Q2	$44.7K	Buy	326 +275	+539%	+$36.7K	﹤0.01%	423
2024 Q1	$7K	Hold	51	–	–	﹤0.01%	536
2023 Q4	$6.93K	Sell	51 -56,434	-100%	-$6.89M	﹤0.01%	501
2023 Q3	$6.91M	Buy	56,485 +537	+1%	+$68.3K	0.47%	70
2023 Q2	$7.1M	Buy	55,948 +1,358	+2%	+$176K	0.47%	75
2023 Q1	$7.05M	Buy	54,590 +523	+1%	+$68.5K	0.48%	78
2022 Q4	$7.1M	Buy	54,067 +239	+0.4%	+$30.9K	0.53%	71
2022 Q3	$6.3M	Buy	53,828 +1,919	+4%	+$238K	0.5%	74
2022 Q2	$6.11M	Buy	51,909 +2,319	+5%	+$275K	0.46%	86
2022 Q1	$6.46M	Buy	49,590 +5,509	+12%	+$718K	0.42%	102
2021 Q4	$6.73M	Buy	44,081 +972	+2%	+$150K	0.42%	94
2021 Q3	$6.97M	Buy	43,109 +1,795	+4%	+$302K	0.45%	85
2021 Q2	$6.76M	Buy	41,314 +1,190	+3%	+$183K	0.44%	86
2021 Q1	$6.04M	Sell	40,124 -883	-2%	-$140K	0.43%	88
2020 Q4	$6.21M	Sell	41,007 -54	-0.1%	-$7.72K	0.46%	77
2020 Q3	$5.56M	Sell	41,061 -239	-0.6%	-$32.4K	0.45%	82
2020 Q2	$5.64M	Sell	41,300 -3,142	-7%	-$401K	0.49%	74
2020 Q1	$4.79M	Buy	44,442 +601	+1%	+$69.2K	0.48%	73
2019 Q4	$5.28M	Buy	43,841 +702	+2%	+$78.3K	0.44%	84
2019 Q3	$4.29M	Buy	43,139 +1,740	+4%	+$182K	0.39%	95
2019 Q2	$4.52M	Buy	41,399 +2,529	+7%	+$269K	0.42%	85
2019 Q1	$4.34M	Buy	38,870 +1,256	+3%	+$138K	0.43%	83
2018 Q4	$3.63M	Buy	37,614 +291	+0.8%	+$30.9K	0.4%	87
2018 Q3	$4.55M	Sell	37,323 -10	-0%	-$1.18K	0.45%	77
2018 Q2	$4.1M	Buy	37,333 +794	+2%	+$84.9K	0.42%	76
2018 Q1	$3.9M	Sell	36,539 -289	-0.8%	-$32K	0.4%	80
2017 Q4	$3.93M	Sell	36,828 -387	-1%	-$41.4K	0.4%	80
2017 Q3	$4.14M	Sell	37,215 -384	-1%	-$41K	0.42%	75
2017 Q2	$3.89M	Sell	37,599 -339	-0.9%	-$33.4K	0.41%	81
2017 Q1	$3.71M	Sell	37,938 -960	-2%	-$91.9K	0.4%	85
2016 Q4	$3.44M	Buy	38,898 +1,332	+4%	+$121K	0.38%	91
2016 Q3	$3.63M	Sell	37,566 -3,483	-8%	-$331K	0.4%	83
2016 Q2	$3.52M	Buy	41,049 +40,350	+5,773%	+$3.62M	0.39%	90
2016 Q1	$61K	Hold	699	–	–	0.01%	256
2015 Q4	$79K	Hold	699	–	–	0.01%	231
2015 Q3	$71K	Hold	699	–	–	0.01%	245
2015 Q2	$86K	Hold	699	–	–	0.01%	241
2015 Q1	$80K	Hold	699	–	–	0.01%	252
2014 Q4	$71K	Hold	699	–	–	0.01%	268
2014 Q3	$64K	Buy	+699	New	+$61.3K	0.01%	271

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

MOTCO's IBB Position: Q2 2026 in Review

MOTCO held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 42 shares worth $7.99K. The position accounts for ﹤0.01% of the portfolio, ranked #450.

MOTCO first reported a position in IBB in Q3 2014 and has held it in 48 quarters since. The position peaked at $7.1M in Q2 2023. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

MOTCO held 42 shares of iShares Biotechnology ETF worth $7.99K as of Q2 2026.
MOTCO left its iShares Biotechnology ETF share count unchanged in Q2 2026.
iShares Biotechnology ETF made up ﹤0.01% of MOTCO's portfolio in Q2 2026, its #450 holding.
MOTCO first reported a position in iShares Biotechnology ETF in Q3 2014 and has held it in 48 quarters since.
MOTCO's iShares Biotechnology ETF position peaked at $7.1M in Q2 2023.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on MOTCO's 13F filing for Q2 2026, filed 31 Jul 2026.